Cargando…

An Update on Antiviral Therapy Against SARS-CoV-2: How Far Have We Come?

COVID-19 pandemic has spread worldwide at an exponential rate affecting millions of people instantaneously. Currently, various drugs are under investigation to treat an enormously increasing number of COVID-19 patients. This dreadful situation clearly demands an efficient strategy to quickly identif...

Descripción completa

Detalles Bibliográficos
Autores principales:	Indari, Omkar, Jakhmola, Shweta, Manivannan, Elangovan, Jha, Hem Chandra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7982669/ https://www.ncbi.nlm.nih.gov/pubmed/33762954 http://dx.doi.org/10.3389/fphar.2021.632677

Ejemplares similares

Mutational analysis of structural proteins of SARS-CoV-2
por: Jakhmola, Shweta, et al.
Publicado: (2021)

SARS-CoV-2, an Underestimated Pathogen of the Nervous System
por: Jakhmola, Shweta, et al.
Publicado: (2020)

Potential Therapeutic Targets and Vaccine Development for SARS-CoV-2/COVID-19 Pandemic Management: A Review on the Recent Update
por: Anand, Uttpal, et al.
Publicado: (2021)

Recent updates on COVID-19: A holistic review
por: Jakhmola, Shweta, et al.
Publicado: (2020)

Microfluidic Platforms to Unravel Mysteries of Alzheimer’s Disease: How Far Have We Come?
por: Prasanna, Pragya, et al.
Publicado: (2021)

Comorbidity Assessment Is Essential During COVID-19 Treatment
por: Jakhmola, Shweta, et al.
Publicado: (2020)

Milestones in Heart Failure: How Far We Have Come and How Far We Have Left to Go
por: Gajjela, Harini, et al.
Publicado: (2021)

A review of the presence of SARS-CoV-2 RNA in wastewater and airborne particulates and its use for virus spreading surveillance
por: Anand, Uttpal, et al.
Publicado: (2021)

Deciphering antiviral efficacy of malaria box compounds against malaria exacerbating viral pathogens- Epstein Barr virus and SARS-CoV-2, an in silico study
por: Indari, Omkar, et al.
Publicado: (2022)

Immunotherapy in myeloma: how far have we come?
por: Franssen, Laurens E., et al.
Publicado: (2019)

Intravenous iron therapy: how far have we come?
por: Cançado, Rodolfo Delfini, et al.
Publicado: (2011)

Best Pharmaceuticals for Children: How Far Have We Come?
por: Mazer-Amirshahi, Maryann, et al.
Publicado: (2014)

Understanding Bioluminescence in Dinoflagellates—How Far Have We Come?
por: Valiadi, Martha, et al.
Publicado: (2013)

Candida glabrata Biofilms: How Far Have We Come?
por: Rodrigues, Célia F., et al.
Publicado: (2017)

Gene Delivery to the Skin – How Far Have We Come?
por: Ain, Qurrat Ul, et al.
Publicado: (2021)

Overcoming Shellfish Allergy: How Far Have We Come? †
por: Wai, Christine Y.Y., et al.
Publicado: (2020)

Calcium imaging analysis – how far have we come?
por: Robbins, Miranda, et al.
Publicado: (2021)

Dysbiosis of Gut Microbiota from the Perspective of the Gut–Brain Axis: Role in the Provocation of Neurological Disorders
por: Kandpal, Meenakshi, et al.
Publicado: (2022)

Paediatric Surgery on the African Continent: How Far Have We Come; How Far Can We Go?
por: Numanoglu, Alp
Publicado: (2023)

Cell therapies for Parkinson's disease: how far have we come?
por: Stoker, Thomas B, et al.
Publicado: (2016)

Metals and Alzheimer’s Disease: How Far Have We Come in the Clinic?
por: Adlard, Paul A., et al.
Publicado: (2018)

Understanding blast-induced neurotrauma: how far have we come?
por: Cernak, Ibolja
Publicado: (2017)

Delineating the Risk of Lupus Nephritis: How Far Have We Come?
por: Lee, Jisoo
Publicado: (2021)

Herpesviral interplay with peroxisome: An underexplored viral niche
por: Indari, Omkar, et al.
Publicado: (2023)

Biomaterials for Testicular Bioengineering: How far have we come and where do we have to go?
por: Horvath-Pereira, Bianca de Oliveira, et al.
Publicado: (2023)

Providing Effective Environmental Enrichment to Pigs: How Far Have We Come?
por: van de Weerd, Heleen, et al.
Publicado: (2019)

Stem-cell transplantation in multiple myeloma: how far have we come?
por: Soekojo, Cinnie Y., et al.
Publicado: (2019)

Place Identity: How Far Have We Come in Exploring Its Meanings?
por: Peng, Jianchao, et al.
Publicado: (2020)

Research for Prevention of Oral/Dental Diseases: How Far Have We Come?
por: Schwendicke, F., et al.
Publicado: (2019)

Thermal Ablation for Papillary Thyroid Microcarcinoma: How Far We Have Come?
por: Min, Yu, et al.
Publicado: (2020)

Editorial: Functional neuroimaging in psychiatric practice: How far have we come?
por: Kundu, Prantik
Publicado: (2023)

Diversity of Tanaidacea (Crustacea: Peracarida) in the World's Oceans – How Far Have We Come?
por: Blazewicz-Paszkowycz, Magdalena, et al.
Publicado: (2012)

Review of Two Decades of Cholera Diagnostics – How Far Have We Really Come?
por: Dick, Michal H., et al.
Publicado: (2012)

Oncolytic virotherapy using herpes simplex virus: how far have we come?
por: Sokolowski, Nicolas AS, et al.
Publicado: (2015)

Training in robotic surgery, replicating the airline industry. How far have we come?
por: Collins, Justin William, et al.
Publicado: (2019)

Immunoglobulin M in Health and Diseases: How Far Have We Come and What Next?
por: Jones, Katelyn, et al.
Publicado: (2020)

The Role of E-Content Development in Medical Teaching: How Far Have We Come?
por: Bankar, Maithili N, et al.
Publicado: (2023)

In Search of a Data-in-Once, Electronic Health Record-Linked, Multicenter Registry—How Far We Have Come and How Far We Still Have to Go
por: Marsolo, Keith
Publicado: (2013)

A view on dendritic cell immunotherapy in ovarian cancer: how far have we come?
por: Coosemans, A., et al.
Publicado: (2015)

How Far Have We Come in the Field of Nerve Regeneration After Trigeminal Nerve Injury?
por: Rosén, Annika, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_b5hm6ss7sqpvmbm3mbqgkfjbct